COVID-19 Vaccine Development and Global Response MCQs are crucial for CSS aspirants studying International Relations, Public Health, and Global Governance. The COVID-19 pandemic, which was caused by SARS-CoV-2, resulted in a historic global effort to develop and deploy vaccines. Scientists, pharmaceutical firms, and governments came together to develop effective vaccines within record time, making mass immunization across the globe possible. Nations adopted public health measures, vaccination campaigns, and economic stimulus packages to counter the effects of the pandemic. Knowledge of vaccine development, distribution issues, and global cooperation is essential for CSS aspirants.
H2: Vaccine Development and Global Immunization Strategies
The race to produce a COVID-19 vaccine brought into existence various vaccine technologies, such as mRNA vaccines (Pfizer-BioNTech, Moderna), viral vector vaccines (AstraZeneca, Sputnik V), and inactivated virus vaccines (Sinopharm, Sinovac). Funding of vaccine research came through organizations such as the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI). COVAX, a Gavi-led initiative in collaboration with WHO and UNICEF, was organized to ensure equitable vaccine distribution to poor nations. Despite this, vaccine nationalism, distribution chain interruptions, and disinformation hindered the attainment of global herd immunity. The scientific developments and global policies that influenced the rollout of the COVID-19 vaccines need to be examined by CSS aspirants.
H3: Pakistan’s Vaccination Drive and Policy Challenges
Pakistan initiated its COVID-19 vaccine campaign in early 2021, targeting frontline healthcare workers, older citizens, and high-risk individuals. Vaccine distribution was controlled by the National Command and Operation Center (NCOC), with the government acquiring doses from COVAX, China (Sinopharm, Sinovac, CanSino), and Western companies (Pfizer, AstraZeneca, Moderna). Free vaccination centers and mobile sites were established across the country to make it more accessible. Misinformation, hesitancy, and logistical problems, though, slowed the pace. Pakistan was able to vaccinate millions successfully by 2022, relaxing pandemic measures. CSS candidates will be able to grasp public health policy, vaccine diplomacy, and crisis management internationally by practicing MCQs and free flashcards on COVID-19 vaccine development and international response.
Which was the first COVID-19 vaccine to receive emergency use authorization?
A) Moderna
B) AstraZeneca
C) Pfizer-BioNTech
D) Sinopharm
Which organization led the global COVAX initiative to distribute vaccines?
A) WHO
B) UNICEF
C) GAVI
D) All of the above
Which technology was used in the Pfizer and Moderna COVID-19 vaccines?
A) Inactivated virus
B) mRNA
C) Adenovirus vector
D) Protein subunit
Which country was the first to approve the Pfizer-BioNTech COVID-19 vaccine?
A) USA
B) UK
C) China
D) Germany
Which vaccine was developed in China and widely distributed in Pakistan?
A) Pfizer
B) Moderna
C) Sinopharm
D) AstraZeneca
Which vaccine uses an adenovirus vector to deliver immunity?
A) Moderna
B) Sinopharm
C) AstraZeneca
D) Novavax
Which country was the first to begin mass COVID-19 vaccinations?
A) USA
B) UK
C) Russia
D) China
What is the recommended number of doses for the Pfizer vaccine?
A) 1
B) 2
C) 3
D) 4
Which COVID-19 variant led to booster dose recommendations?
A) Alpha
B) Beta
C) Delta
D) Gamma
Which of these vaccines does NOT use mRNA technology?
A) Pfizer
B) Moderna
C) AstraZeneca
D) None of the above
Which company developed the first mRNA COVID-19 vaccine?
A) Johnson & Johnson
B) AstraZeneca
C) Moderna
D) Sinovac
Which international organization approved COVID-19 vaccines for global use?
A) IMF
B) WHO
C) WTO
D) UNESCO
Which vaccine was developed by Russia?
A) Sputnik V
B) Covaxin
C) Johnson & Johnson
D) Novavax
What is the primary role of booster doses?
A) Replace primary doses
B) Strengthen immunity
C) Reduce vaccine side effects
D) Shorten immunity duration
Which vaccine was first approved in the USA?
A) Pfizer-BioNTech
B) Sinopharm
C) AstraZeneca
D) Sputnik V
Which organization monitors COVID-19 vaccine safety globally?
A) WHO
B) CDC
C) FDA
D) All of the above
Which vaccine is a single-dose COVID-19 vaccine?
A) AstraZeneca
B) Moderna
C) Johnson & Johnson
D) Pfizer
Which country developed the Covaxin COVID-19 vaccine?
A) China
B) USA
C) India
D) UK
Which COVID-19 vaccine is protein-based?
A) Novavax
B) Pfizer
C) Moderna
D) Sputnik V
Which vaccine was first administered in Pakistan?
A) AstraZeneca
B) Sinopharm
C) Moderna
D) Johnson & Johnson
What is the minimum age for COVID-19 vaccination in most countries?
A) 5 years
B) 12 years
C) 18 years
D) 21 years
Which vaccine was co-developed by Oxford University?
A) Sinopharm
B) AstraZeneca
C) Moderna
D) Sputnik V
Which COVID-19 variant was first detected in South Africa?
A) Alpha
B) Delta
C) Beta
D) Omicron
Which vaccine was primarily used in China?
A) Pfizer
B) Sputnik V
C) Sinopharm
D) Johnson & Johnson
Which regulatory body authorized COVID-19 vaccines in the USA?
A) CDC
B) FDA
C) WHO
D) NIH
What is the primary benefit of mRNA vaccines?
A) No refrigeration needed
B) Faster development
C) One-dose requirement
D) No booster shots needed
Which country developed the Sinovac COVID-19 vaccine?
A) China
B) USA
C) Russia
D) UK
Which COVID-19 vaccine has the highest global distribution?
A) AstraZeneca
B) Sinopharm
C) Pfizer
D) Sputnik V
Which COVID-19 vaccine was linked to rare blood clot cases?
A) AstraZeneca
B) Pfizer
C) Moderna
D) Sinovac
Which global body declared COVID-19 a pandemic?
A) WHO
B) CDC
C) FDA
D) UN
